Journal article

Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus


Authors listKralisch, S; Hoffmann, A; Lössner, U; Kratzsch, J; Blüher, M; Stumvoll, M; Fasshauer, M; Ebert, T

Publication year2017

Pages88-94

JournalMetabolism

Volume number68

ISSN0026-0495

DOI Linkhttps://doi.org/10.1016/j.metabol.2016.11.017

PublisherElsevier


Abstract
Objective. Fetuin B has recently been introduced as a novel adipokine/hepatokine which is significantly increased in hepatic steatosis and mediates impaired insulin action, as well as glucose intolerance. However, regulation of fetuin B in gestational diabetes mellitus (GDM), as well as its longitudinal changes in the peripartum period, have not been elucidated, so far.Design and Methods. Circulating fetuin A and fetuin B were quantified in 74 women with GDM and 74 healthy and gestational age-matched controls by enzyme-linked immunosorbent assay during pregnancy (median gestational age: 201 days). Furthermore, fetuin B was quantified during pregnancy as compared to postpartum levels in a follow-up study (median time after delivery: 4 years and 115 days).Results. Median [interquartile range] serum fetuin B levels were significantly higher in women with GDM (4.8 [1.7] mg/l) as compared to non-diabetic pregnant controls (4.3 [1.2] me) (p = 0.013) during pregnancy. In multivariate analysis, GDM status, insulin resistance, and fetuin A were independent and positive predictors of circulating fetuin B. Furthermore, fetuin B serum concentrations significantly decreased after delivery. from 4.6 [1.7] mg/l (prepartum) to 3.0 [2.2] mg/l (postpartum) in all women (p < 0.001).Conclusions. Women with GDM have significantly higher fetuin B levels as compared to healthy pregrint control women and GDM status, insulin resistance, and fetuin A positively pregnant circulating fetuin B. Postpartum fetuin B is decreased as compared to prepartum values suggesting a placental co-secretion of this novel adipokine/hepatokine. Further studies need to elucidate factors contributing to fetuin B regulation in humans, as well as the pathophysiological significance of fetuin B upregulation in GDM. (C) 2016 Elsevier Inc. All rights reserved.



Citation Styles

Harvard Citation styleKralisch, S., Hoffmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stumvoll, M., et al. (2017) Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus, Metabolism, 68, pp. 88-94. https://doi.org/10.1016/j.metabol.2016.11.017

APA Citation styleKralisch, S., Hoffmann, A., Lössner, U., Kratzsch, J., Blüher, M., Stumvoll, M., Fasshauer, M., & Ebert, T. (2017). Regulation of the novel adipokines/hepatokines fetuin A and fetuin B in gestational diabetes mellitus. Metabolism. 68, 88-94. https://doi.org/10.1016/j.metabol.2016.11.017


Last updated on 2025-21-05 at 16:21